Related Experiment Video
Updated: Jul 5, 2026

Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
How practical are recommendations for dietary control in phenylketonuria?
J H Walter1, F J White, S K Hall
1Willink Biochemical Genetic Unit, Royal Manchester Children's Hospital, Manchester M27 4HA, UK. jhwalter@doctors.org.uk
Insights
Maintaining blood phenylalanine control in phenylketonuria (PKU) is challenging, especially for older children. Treatment adherence and monitoring decrease significantly with age, impacting cognitive outcomes.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Phenylketonuria (PKU) is a genetic disorder requiring lifelong management.
- Blood phenylalanine levels in childhood are critical for cognitive development.
- Age-related treatment guidelines exist to manage PKU.
Purpose of the Study:
- To audit the effectiveness of PKU management between 1994-2000 across four centers.
- To assess adherence to recommended blood phenylalanine levels and sampling frequency.
- To identify age-related challenges in maintaining PKU control.
Main Methods:
- Retrospective audit of PKU patient data from four centers (1994-2000).
- Analysis of blood phenylalanine concentrations against recommended levels.
- Evaluation of blood sampling frequency compared to guidelines.
Main Results:
- Median proportion of samples exceeding recommended phenylalanine levels was <30% for <10 years, but ~80% for ≥15 years.
- Median blood sampling frequency was >80% of recommended for <10 years, but <50% for ≥15 years.
- Difficulty in maintaining metabolic control increases with age in PKU patients.
Conclusions:
- Achieving and maintaining target blood phenylalanine levels is significantly harder in older adolescents and adults with PKU.
- Adherence to monitoring protocols declines with age, posing a risk to long-term health outcomes.
- Improved strategies are needed to ensure consistent PKU management throughout a patient's life.
Abstract:
In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these aims are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control in phenylketonuria, especially in older rather than younger children.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

